PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
2026-05-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
China-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapy
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Aphranel® MagiCCrystal CaHA Filler Achieves EU MDR Certification as a Premium Regenerative Injectable
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Selected for Oral Presentation at WCLC 2026, Demonstrating Sustained Breakthrough Efficacy Signals in NSCLC
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Ribo Announces Phase 2 Clinical Trial Submission to EMA, Further Advancing siRNA Therapeutics in Thromboembolic Disease
2026-05-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
2026-05-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved